{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:14:04Z","timestamp":1791666844170,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Sichuan Science and Technology Program","award":["No.2023NSFSC1847"],"award-info":[{"award-number":["No.2023NSFSC1847"]}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["ZYJC21006"],"award-info":[{"award-number":["ZYJC21006"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-03867-2","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T03:04:44Z","timestamp":1749265484000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparison among Early-Onset, Late-Onset, and Conventional-Onset Adenocarcinoma of Stomach and Esophagogastric Junction: a Retrospective Study"],"prefix":"10.1186","volume":"23","author":[{"given":"Yidi","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Kudriashov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohai","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiankun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,7]]},"reference":[{"issue":"3","key":"3867_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3867_CR2","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1053\/j.gastro.2021.03.023","volume":"161","author":"Y Lin","year":"2021","unstructured":"Lin Y, Zheng Y, Wang HL, Wu J. Global Patterns and Trends in Gastric Cancer Incidence Rates (1988\u20132012) and Predictions to 2030. Gastroenterology. 2021;161(1):116-127.e8.","journal-title":"Gastroenterology"},{"issue":"5","key":"3867_CR3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","volume":"20","author":"AP Thrift","year":"2023","unstructured":"Thrift AP, Wenker TN, El-Serag HB. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention. Nat Rev Clin Oncol. 2023;20(5):338\u201349.","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"3867_CR4","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/ajg.2017.155","volume":"112","author":"M Arnold","year":"2017","unstructured":"Arnold M, Laversanne M, Brown LM, Devesa SS, Bray F. Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030. Am J Gastroenterol. 2017;112(8):1247\u201355.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"3867_CR5","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1136\/gutjnl-2019-320234","volume":"69","author":"M Arnold","year":"2020","unstructured":"Arnold M, Park JY, Camargo MC, Lunet N, Forman D, Soerjomataram I. Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035. Gut. 2020;69(5):823\u20139.","journal-title":"Gut"},{"issue":"10","key":"3867_CR6","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1002\/cam4.3892","volume":"10","author":"Y He","year":"2021","unstructured":"He Y, Wang Y, Luan F, et al. Chinese and global burdens of gastric cancer from 1990 to 2019. Cancer Med. 2021;10(10):3461\u201373.","journal-title":"Cancer Med"},{"issue":"4","key":"3867_CR7","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.surg.2019.04.036","volume":"166","author":"JR Bergquist","year":"2019","unstructured":"Bergquist JR, Leiting JL, Habermann EB, et al. Early-onset gastric cancer is a distinct disease with worrisome trends and oncogenic features. Surgery. 2019;166(4):547\u201355.","journal-title":"Surgery"},{"issue":"4","key":"3867_CR8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s10147-011-0185-7","volume":"16","author":"R Nakamura","year":"2011","unstructured":"Nakamura R, Saikawa Y, Takahashi T, et al. Retrospective analysis of prognostic outcome of gastric cancer in young patients. Int J Clin Oncol. 2011;16(4):328\u201334.","journal-title":"Int J Clin Oncol"},{"key":"3867_CR9","doi-asserted-by":"publisher","first-page":"7378215","DOI":"10.1155\/2020\/7378215","volume":"2020","author":"B Sandeep","year":"2020","unstructured":"Sandeep B, Huang X, Li Y, Mao L, Gao K, Xiao Z. Gastric Carcinoma in Young Patients and Its Clinicopathological Characteristics and Prognosis. Gastroenterol Res Pract. 2020;2020:7378215.","journal-title":"Gastroenterol Res Pract"},{"key":"3867_CR10","doi-asserted-by":"crossref","unstructured":"Radkiewicz C, Asplund J, Lagergren J. Incidence trends and survival in early-onset esophagogastric adenocarcinoma: a Swedish population-based cohort study. Cancer Epidemiol Biomarkers Prev. 2023;32(7):919\u201326.","DOI":"10.1158\/1055-9965.EPI-23-0169"},{"key":"3867_CR11","doi-asserted-by":"crossref","unstructured":"Moreira H, Pinto-de-Sousa J, Carneiro F, Cardoso de Oliveira M, Pimenta A. Early onset gastric cancer no longer presents as an advanced disease with ominous prognosis. Dig Surg. 2009;26(3):215\u2013221.","DOI":"10.1159\/000219331"},{"issue":"1","key":"3867_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ccell.2018.12.003","volume":"35","author":"DG Mun","year":"2019","unstructured":"Mun DG, Bhin J, Kim S, et al. Proteogenomic Characterization of Human Early-Onset Gastric Cancer. Cancer Cell. 2019;35(1):111-124.e10.","journal-title":"Cancer Cell"},{"key":"3867_CR13","doi-asserted-by":"publisher","first-page":"758977","DOI":"10.3389\/fmed.2021.758977","volume":"8","author":"CT Tang","year":"2021","unstructured":"Tang CT, Chen SH. Higher Lymph Node Metastasis Rate and Poorer Prognosis of Intestinal-Type Gastric Cancer Compared to Diffuse-Type Gastric Cancer in Early-Onset Early-Stage Gastric Cancer: A Retrospective Study. Front Med (Lausanne). 2021;8:758977.","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"3867_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S1470-2045(08)70072-X","volume":"9","author":"WK Leung","year":"2008","unstructured":"Leung WK, Wu MS, Kakugawa Y, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008;9(3):279\u201387.","journal-title":"Lancet Oncol."},{"key":"3867_CR15","doi-asserted-by":"crossref","unstructured":"Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14(2):101\u2013112.","DOI":"10.1007\/s10120-011-0041-5"},{"issue":"2","key":"3867_CR16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/jnci\/djad186","volume":"116","author":"MA Lumish","year":"2024","unstructured":"Lumish MA, Walch H, Maron SB, et al. Clinical and Molecular Characteristics of Early-Onset versus Average-Onset Esophagogastric Cancer. J Natl Cancer Inst. 2024;116(2):299\u2013308.","journal-title":"J Natl Cancer Inst."},{"key":"3867_CR17","doi-asserted-by":"publisher","first-page":"1003977","DOI":"10.3389\/fonc.2023.1003977","volume":"13","author":"B Bi","year":"2023","unstructured":"Bi B, Deng GF, Duan YM, et al. Retrospective analysis of risk factors for distant metastasis of early-onset gastric cancer during the perioperative period. Front Oncol. 2023;13:1003977.","journal-title":"Front Oncol"},{"key":"3867_CR18","unstructured":"SEER*Explorer Application. Accessed May 22, 2024. https:\/\/seer.cancer.gov\/statistics-network\/explorer\/application.html?site=18&data_type=1&graph_type=2&compareBy=age_range&chk_age_range_9=9&rate_type=2&sex=1&race=4&stage=101&advopt_precision=1&advopt_show_ci=on&hdn_view=0&advopt_show_apc=on&advopt_display=2"},{"key":"3867_CR19","unstructured":"Cancer of the Stomach - Cancer Stat Facts. SEER. Accessed October 30, 2023. https:\/\/seer.cancer.gov\/statfacts\/html\/stomach.html"},{"issue":"1","key":"3867_CR20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12876-016-0528-y","volume":"16","author":"J Lee","year":"2016","unstructured":"Lee J, Lee MA, Kim IH, Roh SY. Clinical characteristics of young-age onset gastric cancer in Korea. BMC Gastroenterol. 2016;16(1):110.","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"3867_CR21","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1158\/2159-8290.CD-22-1038","volume":"13","author":"I Ben-Aharon","year":"2023","unstructured":"Ben-Aharon I, van Laarhoven HWM, Fontana E, Obermannova R, Nilsson M, Lordick F. Early-Onset Cancer in the Gastrointestinal Tract Is on the Rise-Evidence and Implications. Cancer Discov. 2023;13(3):538\u201351.","journal-title":"Cancer Discov"},{"issue":"2","key":"3867_CR22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s10120-016-0603-7","volume":"20","author":"SJ Merchant","year":"2017","unstructured":"Merchant SJ, Kim J, Choi AH, Sun V, Chao J, Nelson R. A rising trend in the incidence of advanced gastric cancer in young Hispanic men. Gastric Cancer. 2017;20(2):226\u201334.","journal-title":"Gastric Cancer"},{"issue":"6","key":"3867_CR23","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/1097-0142(19900315)65:6<1396::AID-CNCR2820650625>3.0.CO;2-2","volume":"65","author":"CW Wu","year":"1990","unstructured":"Wu CW, Chi CW, Chang TJ, Lui WY, P\u2019eng FK. Sex hormone receptors in gastric cancer. Cancer. 1990;65(6):1396\u2013400.","journal-title":"Cancer"},{"issue":"5","key":"3867_CR24","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/BF00308791","volume":"22","author":"M Matsui","year":"1992","unstructured":"Matsui M, Kojima O, Kawakami S, Uehara Y, Takahashi T. The prognosis of patients with gastric cancer possessing sex hormone receptors. Surg Today. 1992;22(5):421\u20135.","journal-title":"Surg Today"},{"key":"3867_CR25","doi-asserted-by":"publisher","first-page":"7592","DOI":"10.1038\/srep07592","volume":"4","author":"JH Yi","year":"2014","unstructured":"Yi JH, Do IG, Jang J, et al. Anti-tumor efficacy of fulvestrant in estrogen receptor positive gastric cancer. Sci Rep. 2014;4:7592.","journal-title":"Sci Rep"},{"issue":"11","key":"3867_CR26","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1111\/j.1440-1746.2011.06759.x","volume":"26","author":"Y Bai","year":"2011","unstructured":"Bai Y, Li ZS. Endoscopic, clinicopathological features and prognosis of very young patients with gastric cancer. J Gastroenterol Hepatol. 2011;26(11):1626\u20139.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"3867_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.7602\/jmis.2020.23.4.161","volume":"23","author":"KB Park","year":"2020","unstructured":"Park KB, Jun KH. Clinicopathological Features and Prognosis of Gastric Cancer in Young Patients. J Minim Invasive Surg. 2020;23(4):161\u20132.","journal-title":"J Minim Invasive Surg"},{"issue":"6","key":"3867_CR28","first-page":"2757","volume":"12","author":"X Qu","year":"2022","unstructured":"Qu X, Zhao X, Liu Y, et al. The clinicopathological characteristics of early-onset gastric cancer and its evolutionary trends: a retrospective study. Am J Cancer Res. 2022;12(6):2757\u201369.","journal-title":"Am J Cancer Res"},{"key":"3867_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1479-5876-11-58","volume":"11","author":"MZ Qiu","year":"2013","unstructured":"Qiu MZ, Cai MY, Zhang DS, et al. Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China. J Transl Med. 2013;11:58.","journal-title":"J Transl Med."},{"key":"3867_CR30","doi-asserted-by":"publisher","first-page":"674224","DOI":"10.3389\/fonc.2021.674224","volume":"11","author":"Q Huang","year":"2021","unstructured":"Huang Q, Zheng X, Jiao Y, et al. A Distinct Clinicopathological Feature and Prognosis of Young Gastric Cancer Patients Aged \u2264 45 Years Old. Front Oncol. 2021;11:674224.","journal-title":"Front Oncol"},{"issue":"40","key":"3867_CR31","doi-asserted-by":"publisher","first-page":"11428","DOI":"10.3748\/wjg.v21.i40.11428","volume":"21","author":"S Pernot","year":"2015","unstructured":"Pernot S, Voron T, Perkins G, Lagorce-Pages C, Berger A, Taieb J. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge. World J Gastroenterol. 2015;21(40):11428\u201338.","journal-title":"World J Gastroenterol"},{"key":"3867_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7150\/jca.4090","volume":"3","author":"JT J\u00f8rgensen","year":"2012","unstructured":"J\u00f8rgensen JT, Hersom M. HER2 as a Prognostic Marker in Gastric Cancer - A Systematic Analysis of Data from the Literature. J Cancer. 2012;3:137\u201344.","journal-title":"J Cancer"},{"issue":"1","key":"3867_CR33","doi-asserted-by":"publisher","first-page":"237","DOI":"10.21873\/anticanres.15478","volume":"42","author":"Y Takashima","year":"2022","unstructured":"Takashima Y, Komatsu S, Kasuga M, et al. Tumor Location on the Vertical Section of the Anterior Wall Is Related to Favorable Prognosis and Low Incidence of Lymph Node Metastasis in Lower-third Gastric Cancer. Anticancer Res. 2022;42(1):237\u201343.","journal-title":"Anticancer Res"},{"issue":"9","key":"3867_CR34","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1245\/s10434-017-5832-4","volume":"24","author":"F Petrelli","year":"2017","unstructured":"Petrelli F, Ghidini M, Barni S, et al. Prognostic Role of Primary Tumor Location in Non-Metastatic Gastric Cancer: A Systematic Review and Meta-Analysis of 50 Studies. Ann Surg Oncol. 2017;24(9):2655\u201368.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"3867_CR35","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00423-008-0417-0","volume":"394","author":"KH Jun","year":"2009","unstructured":"Jun KH, Jung H, Baek JM, Chin HM, Park WB. Does tumor size have an impact on gastric cancer? A single institute experience. Langenbecks Arch Surg. 2009;394(4):631\u20135.","journal-title":"Langenbecks Arch Surg"},{"issue":"16","key":"3867_CR36","doi-asserted-by":"publisher","first-page":"14941","DOI":"10.1007\/s00432-023-05210-2","volume":"149","author":"H Lai","year":"2023","unstructured":"Lai H, Zheng J, Zhou G, Li Y. Clinical characteristics and prognostic outcomes for adenocarcinoma of esophagogastric junction in early-onset patients: a population-based appraisal. J Cancer Res Clin Oncol. 2023;149(16):14941\u201352.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"3867_CR37","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s13304-022-01313-6","volume":"74","author":"FR Takeda","year":"2022","unstructured":"Takeda FR, Ramos MFKP, Pereira MA, et al. Tumor size predicts worse prognosis in esophagogastric junction adenocarcinoma. Updates Surg. 2022;74(6):1871\u20139.","journal-title":"Updates Surg"},{"key":"3867_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1477-7819-8-111","volume":"8","author":"M Stamatakos","year":"2010","unstructured":"Stamatakos M, Palla V, Karaiskos I, et al. Cell cyclins: triggering elements of cancer or not? World J Surg Oncol. 2010;8:111.","journal-title":"World J Surg Oncol"},{"key":"3867_CR39","doi-asserted-by":"publisher","first-page":"6673","DOI":"10.2147\/OTT.S171716","volume":"11","author":"HP Zhang","year":"2018","unstructured":"Zhang HP, Li SY, Wang JP, Lin J. Clinical significance and biological roles of cyclins in gastric cancer. Onco Targets Ther. 2018;11:6673\u201385.","journal-title":"Onco Targets Ther"},{"issue":"4","key":"3867_CR40","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1053\/j.gastro.2015.06.003","volume":"149","author":"RS van der Post","year":"2015","unstructured":"van der Post RS, Vogelaar IP, Manders P, et al. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1. Gastroenterology. 2015;149(4):897-906.e19.","journal-title":"Gastroenterology"},{"issue":"1","key":"3867_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1001\/jamaoncol.2014.168","volume":"1","author":"S Hansford","year":"2015","unstructured":"Hansford S, Kaurah P, Li-Chang H, et al. Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond. JAMA Oncol. 2015;1(1):23\u201332.","journal-title":"JAMA Oncol"},{"issue":"2","key":"3867_CR42","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/CEJ.0000000000000776","volume":"32","author":"K Hu","year":"2023","unstructured":"Hu K, Zheng QM, Wang YP, Zhao MM, Sun ZG. Clinical and prognostic features of E-cadherin in adenocarcinoma of the esophagogastric junction patients. Eur J Cancer Prev. 2023;32(2):119\u201325.","journal-title":"Eur J Cancer Prev"},{"issue":"1","key":"3867_CR43","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4143\/crt.2016.054","volume":"49","author":"SH Chang","year":"2017","unstructured":"Chang SH, Kim SN, Choi HJ, et al. Adjuvant Chemotherapy for Advanced Gastric Cancer in Elderly and Non-elderly Patients: Meta-Analysis of Randomized Controlled Trials. Cancer Res Treat. 2017;49(1):263\u201373.","journal-title":"Cancer Res Treat"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03867-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03867-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03867-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T03:04:47Z","timestamp":1749265487000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03867-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,7]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3867"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03867-2","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,7]]},"assertion":[{"value":"19 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The retrospective database was approved by the Special Committee on Clinical Trials and Biomedical Ethics at West China Hospital (Approval No. 215 of 2014).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"222"}}